The Sky Shop For Hope
$100 Mystery Box
$100 Mystery Box
Couldn't load pickup availability
The $100 Mystery Box is the ultimate surprise experience from Cure Cancer Shop. Known as the Big Kahuna, this premium box may feature a carefully curated collection of exciting items or one standout premium product chosen to make a lasting impression. Every delivery is designed to bring joy, inspire generosity, and create a deeper connection to our mission.
Every purchase of the Big Kahuna directly supports Sky Foundation, a nonprofit dedicated to pancreatic cancer awareness and research. That means whether you receive multiple treasures or one extraordinary item, your box carries the power to fuel progress and hope in the fight against pancreatic cancer.
This is the perfect choice for those who want to give at the highest level while enjoying the thrill of discovery. The $100 Big Kahuna Mystery Box combines surprise, value, and purpose, making it the most impactful option in our mystery box collection.
FAQ Section
Q: What comes in the $100 Big Kahuna Mystery Box?
A: Each month you’ll receive either a curated collection of items or one premium product from the Cure Cancer Shop. Every Big Kahuna box is designed to be unique and memorable.
Q: When will I receive my box?
A: Boxes ship monthly and typically arrive within 5–7 business days after shipping. You’ll receive tracking information as soon as your order is on its way.
Q: How does my purchase support Sky Foundation?
A: Every Big Kahuna Mystery Box directly funds Sky Foundation’s mission to raise awareness and fuel groundbreaking research for pancreatic cancer. Your generosity makes an immediate impact.
Share

Recent News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...